SCHEMBL24282575

SCHEMBL24282575

CCN(C)N1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723749 0.94
SCHEMBL4722164 0.92 KDM4E (0.31)
Hydrochloric Acid SCHEMBL30552228 0.89 KDM4E (0.31)
SCHEMBL21346907 0.88
SCHEMBL3586396 0.76 GNAI3 (0.31)
SCHEMBL4724222 0.76 SMN1; SMN2 (0.37)
SCHEMBL4721850 0.76 POLB (0.32)
SCHEMBL21613654 0.73 NPC1 (0.32)
SCHEMBL8718542 0.73
SCHEMBL26003792 0.72 DNM1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108276382-B Cyclin-dependent kinase inhibitor and application thereof 南京圣和药物研发有限公司 2022-10-18 CN disclosed
EP-3985013-A1 ROMO1-DERIVED ANTIMICROBIAL PEPTIDES INCLUDING LYSINE SUBSTITUTION AND VARIANTS THEREOF Korea University Research and Business Foundation (KR) 2022-04-20 EP disclosed